Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Hims & Hers Health Inc
(NY:
HIMS
)
14.73
+0.09 (+0.61%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 29, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Hims & Hers Health Inc
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Why Is Hims & Hers (HIMS) Stock Up 24% Today?
November 08, 2022
Hims & Hers (HIMS) stock is climbing higher on Tuesday after reporting results for the third quarter of 2022 and increasing guidance.
Via
InvestorPlace
Where Hims & Hers Health Stands With Analysts
November 08, 2022
Analysts have provided the following ratings for Hims & Hers Health (NYSE:HIMS) within the last quarter:
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2022
November 08, 2022
Upgrades
Via
Benzinga
This Stock Could 10X in 5 Years
November 02, 2022
An assessment of the company's prospects reveal an ecouraging outlook.
Via
The Motley Fool
4 Analysts Have This to Say About Hims & Hers Health
August 10, 2022
Within the last quarter, Hims & Hers Health (NYSE:HIMS) has observed the following analyst ratings:
Via
Benzinga
Hims & Hers Health: Q2 Earnings Insights
August 08, 2022
Hims & Hers Health (NYSE:HIMS) reported its Q2 earnings results on Monday, August 8, 2022 at 04:15 PM. Here's what investors need to know about the announcement.
Via
Benzinga
SVB Securities Sees 26% Downside In This Telehealth Platform
July 15, 2022
Via
Benzinga
SolarEdge Technologies, LivePerson, TaskUs And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
November 08, 2022
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
November 08, 2022
We're starting off the day with a look at the biggest pre-market stock movers traders need to know about on Tuesday morning!
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
November 08, 2022
Gainers NeuroBo Pharmaceuticals (NASDAQ:NRBO) shares rose 49.1% to $3.22 during Tuesday's pre-market session. The company's market cap stands at $2.8 million.
Via
Benzinga
Why TripAdvisor Shares Are Trading Sharply Lower; Here Are 29 Stocks Moving Premarket
November 08, 2022
Gainers
Via
Benzinga
Hims & Hers Partners With Carbon Health
March 30, 2022
Hims & Hers Health Inc (NYSE: HIMS) has partnered with healthcare provider Carbon Health to enable access to a broader range of care options through its...
Via
Benzinga
Earnings Preview For Hims & Hers Health
November 04, 2022
Hims & Hers Health (NYSE:HIMS) is set to give its latest quarterly earnings report on Monday, 2022-11-07. Here's what investors need to know before the announcement. Analysts estimate that Hims & Hers...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 17, 2022
October 17, 2022
Upgrades
Via
Benzinga
What 4 Analyst Ratings Have To Say About Hims & Hers Health
October 17, 2022
Over the past 3 months, 4 analysts have published their opinion on Hims & Hers Health (NYSE:HIMS) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
What 4 Analyst Ratings Have To Say About Hims & Hers Health
September 07, 2022
Over the past 3 months, 4 analysts have published their opinion on Hims & Hers Health (NYSE:HIMS) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2022
September 07, 2022
Upgrades
Via
Benzinga
Hims & Hers Health's Return on Invested Capital Overview
August 31, 2022
Benzinga Pro data, Hims & Hers Health (NYSE:HIMS) reported Q2 sales of $113.56 million. Earnings fell to a loss of $19.68 million, resulting in a 21.09% decrease from last quarter.
Via
Benzinga
What Is Going on With Teladoc (TDOC) Stock Today?
August 25, 2022
With Amazon dropping out of the telehealth business, Teladoc Health moved higher though TDOC stock may struggle longer term.
Via
InvestorPlace
Earnings Preview For Hims & Hers Health
August 05, 2022
Hims & Hers Health (NYSE:HIMS) is set to give its latest quarterly earnings report on Monday, 2022-08-08. Here's what investors need to know before the announcement. Analysts estimate that Hims & Hers...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 15, 2022
July 15, 2022
Via
Benzinga
3 Stocks Under $5 Insiders Are Aggressively Buying
June 17, 2022
U.S. stocks closed sharply lower, with the Nasdaq Composite dipping around 450 on Thursday. Investors, meanwhile, focused on some notable insider trades.
Via
Benzinga
7 Penny Stocks That Actually Have Analyst Buy Ratings
June 14, 2022
Many penny stocks (stocks trading for less than $5 per share) have little analyst coverage, but these seven have sell-side "buy" ratings.
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's After-Market Session
May 06, 2022
Gainers Kiromic BioPharma (NASDAQ:KRBP) stock increased by 12.6% to $0.58 during Friday's after-market session. The market value of their outstanding shares is at $8.9 million.
Via
Benzinga
Earnings Preview For Hims & Hers Health
May 06, 2022
Hims & Hers Health (NYSE:HIMS) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to know before the announcement. Analysts estimate that Hims & Hers...
Via
Benzinga
This Company Is Reportedly Solving Bedroom Performance Issues Behind Closed Doors
May 05, 2022
This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 14, 2022
April 14, 2022
Upgrades
Via
Benzinga
Hims & Hers Health Expands Skincare Offerings
March 29, 2022
Hims & Hers Health Inc (NYSE: HIMS) has expanded its skincare collections, including a facial cleanser, moisturizer, daily SPF, spot corrector, and face oil....
Via
Benzinga
What Cramer Thinks About Hims & Hers Health, Gilead Sciences And More
March 21, 2022
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes Healthcare Realty Trust Incorporated (NYSE: HR) as the company’s merger with Healthcare Trust of America, Inc.
Via
Benzinga
7 Cheap Stocks to Buy If You Only Have $100 to Spend
March 11, 2022
You can find many good stocks to buy for under $10. And here are seven cheap stocks that are good buys even if you only have $100 to spend.
Via
InvestorPlace
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.